Innoviva Inc (INVA)

Exchange
NASDAQ
Symbol
INVA
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    19.95
  • High
    20.29
  • Low
    19.92
  • Close
    19.92
  • Volume
    733,831

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
2.95
Receivables turnover
4.18
Payables turnover
17.87
Working capital turnover
—
Days of inventory on hand (DOH)
123.89
Days of sales outstanding (DSO)
87.23
Number of days of payables
20.43
Fixed asset turnover
603.12
Total asset turnover
0.23
 Liquidity ratios
Current ratio
0.96
Quick ratio
7.18
Cash ratio
5.35
Cash conversion cycle
190.70
 Solvency ratios
Debt-to-assets ratio
0.36
Debt-to-capital ratio
0.40
Debt-to-equity ratio
0.66
Financial leverage ratio
1.84
Interest coverage
11.13
 Profitability ratios
Gross profit margin
58.80%
Operating profit margin
5.96%
Pretax margin
66.62%
Net profit margin
61.70%
Operating return on assets (Operating ROA)
1.40%
Return on assets (ROA)
14.45%
Return on total capital
19.02%
Return on equity (ROE)
26.63%